Amneal Pharmaceuticals Inc (AMRX): Operating Margin

Public company logo of Amneal Pharmaceuticals, Inc. (AMRX)

Scaling risks for Amneal Pharmaceuticals (AMRX) are linked to a dependence on plant automation and the breadth of its product portfolio. Tracking the operating margin confirms the business's resilience, where 16.40 represents the current value of the metric. Stability is underpinned by a reputation as a reliable supplier of high-quality biosimilars, while steady cash flow is guaranteed by the inertia of high demand for affordable generics, eliminating any signs of declining operational activity.

Amneal Pharmaceuticals, Inc. (AMRX): Operating Profitability from 07/04/2022 to 11/20/2026

Amneal Pharmaceuticals (AMRX) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
- stock exchange capitalization data:
Fundamental company valuation:Amneal Pharmaceuticals, Inc., AMRX
Core merchandise of Amneal Corp

The financial stability of Amneal Pharmaceuticals (AMRX) is based on the flawless trust of distributors in generic supplies, which minimizes operational risks. By analyzing the core business margin, an investor assesses the share of operating profit in total revenue before taxes and interest, determining cost management efficiency and the fundamental evolution of business profitability through the price action on this chart.

Main competitors

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Operating Profitability Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Operating Margin|Profitability of Operations Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Operating Profitability|anipharmaceuticals.com - Operating Profit Rate|Operating Sales Margin MNKD|AMPH: Operating Profit Rate|Operating Profitability pacira.com (PCRX)|Operating Margin ARS Pharma (SPRY)|Theravance Biopharma - Operating Sales Margin|Operating Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Operating Sales Margin|Operating Return on Sales Tectonic Therapeutic|TNXP: Operating Margin|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.